Financhill
Back

Tempest Therapeutics, Inc. Stock Predictions

Tempest Therapeutics, Inc. Stock Forecast

  • Is Tempest Therapeutics, Inc. Stock Undervalued?
    The current Tempest Therapeutics, Inc. [TPST] share price is $3.12. The Score for TPST is 10, which is 80% below its historic median score of 50, and infers higher risk than normal.
  • TPST is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.

Will Tempest Therapeutics, Inc. Stock Go Up Next Year?

Data Unavailable

Tempest Therapeutics, Inc. Stock Rating

Data Unavailable

Tempest Therapeutics, Inc. Stock Price History

Is TPST stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TPST is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
tempesttx.com

52-Week Data

52-Week High:
13.65
52-Week Low:
2.87

Prediction Charts

Market Cap:
11.5M
Price in USD:
3.12
Volume:
135.8K
Beta:
-0.19

Technical Analysis

SMA50:
7.14
SMA100:
8.41
SMA200:
8.04
52-Wk Change:
-66.67%

Stock Predictions

  • Is Tempest Therapeutics, Inc. stock public?
    Yes, Tempest Therapeutics, Inc. is a publicly traded company.
  • What is the Tempest Therapeutics, Inc. stock quote today?
    The Tempest Therapeutics, Inc. stock price is 3.12 USD today.
  • How to buy Tempest Therapeutics, Inc. stock online?
    You can buy Tempest Therapeutics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Dec-2 3.06 3.03 3.14 3.00
Dec-3 3.02 3.27 3.34 3.01
Dec-4 3.32 3.42 3.48 3.25
Dec-5 3.42 3.12 3.50 3.11
Dec-8 3.15 3.11 3.20 3.04
Dec-9 3.15 3.20 3.23 3.15
Dec-10 3.22 3.15 3.22 3.11
Dec-11 3.10 3.16 3.23 3.10
Dec-12 3.16 3.11 3.19 3.06
Dec-15 3.05 2.94 3.06 2.87
Dec-16 2.90 2.91 3.00 2.89
Dec-17 2.93 2.93 3.07 2.92
Dec-18 3.02 2.98 3.07 2.93
Dec-19 3.00 3.12 3.20 2.96

Tempest Therapeutics, Inc. Earnings

Data Unavailable

Tempest Therapeutics, Inc. Forecast Revenue Growth

Data Unavailable

  • Analysts estimate an earnings increase this quarter of $0.76 per share, a decrease next quarter of $0.00 per share, an increase this year of $15.17 per share, and a decrease next year of $14.10 per share.

* Tempest Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.